**UnitedHealth Group (UNH)**:
* Unitedhealth Group Inc is a equity in the USA market.
* The price is 307.42 USD currently with a change of 3.99 USD (0.01%) from the previous close.
* The latest open price was 304.96 USD and the intraday volume is 14930045.
* The intraday high is 310.57 USD and the intraday low is 303.9 USD.
* The latest trade time is Saturday, August 23, 03:57:37 +0400.
---
### Key Highlights:
* **Current Price**: Approximately **\$307.42**, reflecting a **1.34% increase** from the previous close ( , ).
* **Daily Range**: Between **\$303.90** and **\$310.57**, with an opening price around **\$304.96** .
* **Volume**: Around **14.93 million shares**, close to the platform-reported figure ( ).
* **52-Week Range**: From a low of **\$234.60** to a high of **\$630.73** ( ).
* **Analyst Ratings**:
* Consensus: **Buy**
* Average Price Target: **\$397.78**, implying \~29% upside potential ( ).
---
### Recent Developments & Insights:
* **Berkshire Hathaway Boosts Confidence**
Warren Buffett’s Berkshire Hathaway recently acquired **5 million shares** of UNH, sparking a \~14% rally in the stock, signaling confidence in its long-term potential despite recent underperformance ( ).
* **Medicare Advantage Headwinds**
Analysts, including those at Bank of America, caution that changes to the Medicare Advantage rating system and reimbursements may pressure UnitedHealth’s profitability through 2028. A recent **5.06% increase** in reimbursement rates offers some optimism, but potential coding changes remain a significant risk ( ).
* **Mixed Market Context**
On August 22, UNH rose 1.34% to **\$307.42**, compared to Humana (+1.71%) and Elevance Health (+2.24%) ( ). The previous day (Aug 21), UNH climbed 1.17% to **\$303.35**, outperforming Elevance and Chubb, though Humana still led the gains ( ).
---
### Quick Summary Table
| Item | Details |
| --------------------- | -------------------------------- |
| **Current Price** | \~\$307.42 |
| **Intraday Range** | \~\$303.90 – \~\$310.57 |
| **Volume** | \~14.9M shares |
| **52-Week Range** | \$234.60 – \$630.73 |
| **Analyst Sentiment** | Buy, Target: \~\$397.78 |
| **Recent Driver** | Berkshire Hathaway purchase |
| **Risks Ahead** | Medicare Advantage policy shifts |
---
### What Would You Like Next?
Want to dive deeper? I can pull up:
* Upcoming **earnings dates and forecasts**
* **Dividend history** and yield trends
* **Historical performance charts**
* Or compare UNH against its healthcare peers like Humana or Elevance Health
Just let me know where you'd like to go next!